OUR MISSION TRANSFORMING TRANSFUSION DIAGNOSTICS AND BEYOND We continually innovate to achieve new heights in diagnostics. We are a commercial-stage diagnostics company that is fully committed to delivering solutions that reshape the way diagnostics is practiced. Our fundamental objective is to empower our customers to realize their full potential and improve their business. Together, we are transforming transfusion diagnostics and beyond. Originally established in Scotland in the 1940s as Alba Bioscience, Quotient’s then research and manufacturing subsidiary manufactured blood typing reagents as part of the Scottish National Blood Transfusion Service (SNBTS). In addition to supplying its products throughout the Scottish National Health System, Alba Bioscience expanded its operations and subsequently emerged as an original equipment manufacturer (OEM) supplier to the world’s leading transfusion diagnostics companies. In 2007, Alba Bioscience was privatized and became part of what is now known as Quotient. Building on our strong heritage in transfusion diagnostics, in 2013, we introduced our proprietary multimodality multiplexing microarray technology, MosaiQ™, which represents the world’s first fully automated, consolidated testing platform. MosaiQ™ is a game-changing solution that was designed to increase efficiencies, improve clinical practice, deliver significant workflow improvements, and reduce operational costs within laboratories throughout the world. In response to the global effort to combat COVID-19, Quotient developed the MosaiQ COVID-19 Antibody Microarray which is CE marked and has received the U.S. FDA Emergency Use Authorization. Quotient currently has offices in Eysins, Switzerland; Edinburgh, Scotland; and Newtown, Pennsylvania. Management Manuel O. Méndez, Chief Executive Officer Ali Kiboro, Chief Financial Officer Christian Albrich, Chief People Officer Mohammad El Khoury, Chief Commercial Officer Dr. Christine Ginocchio, Chief Scientific & Medical Officer Dr. Michael Hausmann, Chief Technology Officer Careers Quotient currently employs more than 400 expert professionals who are all working toward the same goal: To transform transfusion diagnostics and beyond. Joining Quotient represents a valuable opportunity to become part of a groundbreaking team that is set to re-shape the future and potential of diagnostics. LEARN MORE Media Read Quotient’s recent press releases, download our media kit, and discover the latest news about our industry and products. LEARN MORE Corporate Governance The board of directors of Quotient Limited sets high standards for the company’s employees, officers and directors? Implicit in this philosophy is the importance of sound corporate governance. READ MORE Gender pay report The gender pay gap shows the difference between the average earnings of men and women at Quotient. READ MORE Latest updates EVENT & PRESENTATION SFTS Congress 2021 PRESS RELEASE Quotient Limited Announces Equity Awards PRESS RELEASE Quotient Limited Provides Second Quarter Fiscal 2022 Results READ ALL MENU QUICK ACTIONS Linkedin Twitter Vimeo THE FUTURE, MADE POSSIBLE. © Copyright 2021, All Rights Reserved. PRIVACY POLICY LEGAL NOTICE We use cookies on this site to enhance your user experience By clicking the Accept and Proceed button, you agree to our privacy policy. ACCEPT AND PROCEED